Evidence map›Paper›PMID 40461494›Full record

ArticleNPJ Parkinson's disease2025

Resilience of striatal synaptic plasticity over early structural adaptations in premotor parkinsonism.

Leyre Merino-Galán, Marta Zamarbide, Arantzazu Belloso-Iguerategui, Marta C Alonso-Moreno, Belén Gago, Alejandro Reinares-Sebastián, Javier Blesa, Dani Dumitriu, Ana Quiroga-Varela, María Cruz Rodríguez-Oroz

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Leyre Merino-GalánNeuroscience Programme, Centre for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain.
Marta ZamarbideNeuroscience Programme, Centre for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain.
Arantzazu Belloso-IguerateguiNeuroscience Programme, Centre for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain.
Marta C Alonso-MorenoNeuroscience Programme, Centre for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain.
Belén GagoUniversidad de Málaga, IBIMA- Plataforma BIONAND, Facultad de Medicina, Málaga, Spain.
Alejandro Reinares-SebastiánHM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
Javier BlesaHM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
Dani DumitriuCenter for Early Relational Health, Columbia University Irving Medical Center, New York, NY, USA.
Ana Quiroga-Varela *Neuroscience Programme, Centre for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain.
María Cruz Rodríguez-Oroz *Neuroscience Programme, Centre for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain. mcroroz@unav.es.

Funding

Aligning Science Across Parkinson's, Michael J. Fox Foundation for Parkinson's Research (MJFF) ASAP-020505Instituto de Salud Carlos III PI14/00763Miguel Servet Program, Instituto de Salud Carlos III CP19/00200
6 · The paper itself

Abstract

Parkinson's disease has a long premotor phase with ongoing dopaminergic degeneration, yet its compensatory mechanisms remain unclear. Using a rat model with A53T α-synuclein overexpression in the substantia nigra, we analyzed striatal synaptic changes at 72 h, 1, 2, and 4 weeks post-inoculation, before motor signs appeared. Dopamine concentration decreased from 72 h, and chemical long-term potentiation was simultaneously inhibited, partially recovering by 4 weeks. At this time point, dopaminergic degeneration and post-synaptic morphological and ultrastructural dendritic spine remodelling became significant. These changes included a reduction in thin dendritic spines, an increase in mushroom spine head volume, a decrease in smooth endoplasmic reticulum-containing spines, and an increase in dendritic branching. In conclusion, impaired striatal dopaminergic neurotransmisson diminishes striatal synaptic plasticity, which can be partially restored through complex structural changes in striatal spines. These adaptations might represent fundamental homeostatic mechanisms regulating synaptic function during the premotor stage of Parkinson's disease.

Identifiers

PMID40461494
PMCPMC12134346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.